Dalazatide TFA

Tax included
Dalazatide (ShK-186) TFA is a specific Kv1.3 potassium channel peptide inhibitor. Dalazatide TFA can be used in the study of autoimmune diseases such as multiple sclerosis (MS), lupus erythematosus, psoriasis, rheumatoid arthritis, type 1 diabetes and inflammatory bowel disease.
MedChemExpress 
HY-P3507A

Data sheet

Size
Multiple sizes
Reactivity
Potassium Channel
Application
Metabolism-protein/nucleotide metabolism